Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance

Updated on: March 08,2024

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance

Updated on:March 08,2024

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance

Updated on: January 07,2024

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance

Updated on:January 07,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on: May 21,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on:May 21,2024

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn a recently published editorial in the journalGenes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hosp

Updated on: January 16,2024

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn a recently published editorial in the journalGenes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hosp

Updated on:January 16,2024

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on: April 01,2024

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on:April 01,2024

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Updated on: April 09,2024

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Updated on:April 09,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on: May 05,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on:May 05,2024

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on: January 03,2024

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on:January 03,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on: August 03,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on:August 03,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on: January 12,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on:January 12,2024